Literature DB >> 18632926

Rapid immunochromatographic strip test for detection of anti-K39 immunoglobulin G antibodies for diagnosis of visceral leishmaniasis.

Ryan J Welch1, Brian L Anderson, Christine M Litwin.   

Abstract

InBios International has developed an immunochromatographic rapid strip for the detection of visceral leishmaniasis that requires minimal equipment and only a small amount of blood to run a test. We compared the InBios rapid strip test with the CDC immunofluorescent antibody assay, and the agreement, sensitivity, and specificity were 98%, 90%, and 100%, respectively.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18632926      PMCID： PMC2546669          DOI： 10.1128/CVI.00174-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  15 in total

1.  Rapid accurate field diagnosis of Indian visceral leishmaniasis.

Authors:  S Sundar; S G Reed; V P Singh; P C Kumar; H W Murray
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

2.  Visceral leishmaniasis in a soldier returning from Operation Enduring Freedom.

Authors:  Eric S Halsey; L Michelle Bryce; Glenn W Wortmann; Peter J Weina; Jeffrey R Ryan; Caroline C DeWitt
Journal:  Mil Med       Date:  2004-09       Impact factor: 1.437

3.  Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood.

Authors:  E Nuzum; F White; C Thakur; R Dietze; J Wages; M Grogl; J Berman
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

4.  Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.

Authors:  S Sundar; M Sahu; H Mehta; A Gupta; U Kohli; M Rai; J D Berman; H W Murray
Journal:  Clin Infect Dis       Date:  2002-07-31       Impact factor: 9.079

5.  Two cases of visceral leishmaniasis in U.S. military personnel--Afghanistan, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-04-02       Impact factor: 17.586

6.  Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib; P A Kager
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Sep-Oct       Impact factor: 2.184

7.  Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources.

Authors:  J Seaman; A J Mercer; H E Sondorp; B L Herwaldt
Journal:  Ann Intern Med       Date:  1996-04-01       Impact factor: 25.391

8.  Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.

Authors:  J M Burns; W G Shreffler; D R Benson; H W Ghalib; R Badaro; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 9.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

Review 10.  Serodiagnosis of leishmaniasis.

Authors:  K Kar
Journal:  Crit Rev Microbiol       Date:  1995       Impact factor: 7.624
View more
  7 in total

1.  Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Authors:  A C Vallur; A Hailu; D Mondal; C Reinhart; H Wondimu; Y Tutterrow; H W Ghalib; S G Reed; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

Review 2.  Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis.

Authors:  Malcolm S Duthie; Aurore Lison; Orin Courtenay
Journal:  Trends Parasitol       Date:  2018-08-18

3.  Development and validation of serological markers for detecting recent Plasmodium vivax infection.

Authors:  Rhea J Longley; Michael T White; Eizo Takashima; Jessica Brewster; Masayuki Morita; Matthias Harbers; Thomas Obadia; Leanne J Robinson; Fumie Matsuura; Zoe S J Liu; Connie S N Li-Wai-Suen; Wai-Hong Tham; Julie Healer; Christele Huon; Chetan E Chitnis; Wang Nguitragool; Wuelton Monteiro; Carla Proietti; Denise L Doolan; Andre M Siqueira; Xavier C Ding; Iveth J Gonzalez; James Kazura; Marcus Lacerda; Jetsumon Sattabongkot; Takafumi Tsuboi; Ivo Mueller
Journal:  Nat Med       Date:  2020-05-11       Impact factor: 53.440

4.  rK39 antigen for the diagnosis of visceral leishmaniasis by using human saliva.

Authors:  Manisha Vaish; Om Prakash Singh; Jaya Chakravarty; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 5.  Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.

Authors:  Marleen Boelaert; Kristien Verdonck; Joris Menten; Temmy Sunyoto; Johan van Griensven; Francois Chappuis; Suman Rijal
Journal:  Cochrane Database Syst Rev       Date:  2014-06-20

6.  Prevalence of canine leishmaniasis in Beichuan County, Sichuan, China and phylogenetic evidence for an undescribed Leishmania sp. in China based on 7SL RNA.

Authors:  Ke Sun; Wang Guan; Jian-Guo Zhang; Ya-Jing Wang; Yu Tian; Lin Liao; Bin-Bin Yang; Da-Li Chen; Jian-Ping Chen
Journal:  Parasit Vectors       Date:  2012-04-19       Impact factor: 3.876

7.  VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy.

Authors:  Ana Maria Fonseca; Raquel González; Azucena Bardají; Chenjerai Jairoce; Maria Rupérez; Alfons Jiménez; Llorenç Quintó; Pau Cisteró; Anifa Vala; Charfudin Sacoor; Himanshu Gupta; Jennifer Hegewisch-Taylor; Joe Brew; Nicaise Tuikue Ndam; Simon Kariuki; Marta López; Carlota Dobaño; Chetan E Chitnis; Peter Ouma; Michael Ramharter; Salim Abdulla; John J Aponte; Achille Massougbodji; Valerie Briand; Ghyslain Mombo-Ngoma; Meghna Desai; Michel Cot; Arsenio Nhacolo; Esperança Sevene; Eusebio Macete; Clara Menéndez; Alfredo Mayor
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.